Funded Startups in Kelowna
Across the 18 most recent Kelowna funding entries, the largest disclosed amount is Fission Uranium’s $56M round dated 2024-02-05.
Across the 18 most recent Kelowna funding entries, the largest disclosed amount is Fission Uranium’s $56M round dated 2024-02-05. That figure is an outlier relative to the rest of the disclosed rounds, which mostly cluster below the $10M range, with several entries at $4M or $2M (for example, F3 Uranium $4M on 2026-04-02; MYND Life Sciences $2M on 2025-02-11; Diamcor Mining $2M on 2024-01-18). Another concentration shows up in the February 2024 window: three separate financings land between 2024-02-05 ($56M), 2024-02-13 (Minga, $7M), and 2024-02-11 (MYND Life Sciences, $2M).
Sector patterns also stand out. “Biotechnology” appears in three entries (MYND Life Sciences 2025-02-11 $2M; Tryp Therapeutics 2023-04-12 $2M; The Valens Company 2021-12-16 $31M), while “Energy” also appears in three entries (F4 Uranium 2026-06-16 $710K; F3 Uranium 2026-04-02 $4M; Fission Uranium 2024-02-05 $56M). From a stage/disclosure perspective, 8 of the 18 rows are labeled “Series Unknown,” and 2 rows use “undisclosed” amounts (CRWN.ai 2026-04-16; Red Leaf Pulp 2023-09-19). Dates span from 2021-12-16 (The Valens Company) to 2026-06-16 (F4 Uranium).
Most recent rounds
18 shownRelated listings
Frequently asked
What’s the biggest disclosed round in this Kelowna list, and how far above the rest is it?
Fission Uranium’s $56M disclosed round on 2024-02-05 is the largest disclosed amount in the 18-row view. It stands well above other disclosed entries that frequently sit at $4M, $2M, or below (for example, Cantex Mine Development $4M on 2025-07-11; MYND Life Sciences $2M on 2025-02-11; Diamcor Mining $2M on 2024-01-18).
Are there tight timing clusters in the dates shown?
Yes. Three rounds fall within a narrow February 2024 period: Fission Uranium closes on 2024-02-05 for $56M, Minga closes on 2024-02-13 for $7M, and MYND Life Sciences closes on 2025-02-11 is outside—so the cluster is specifically anchored by 2024-02-05 and 2024-02-13, with 2024-01-18 (Diamcor Mining $2M) immediately preceding. The page also shows a broader jump from 2023-07–10 to 2024-04 (e.g., Avant $4M on 2023-07-17; Summit $4M on 2024-04-04).
Which sectors are over-represented across multiple entries?
Biotechnology appears three times (MYND Life Sciences $2M on 2025-02-11; Tryp Therapeutics $2M on 2023-04-12; The Valens Company $31M on 2021-12-16). Energy also appears three times (F4 Uranium $710K on 2026-06-16; F3 Uranium $4M on 2026-04-02; Fission Uranium $56M on 2024-02-05).
How dominant are “Series Unknown” and “undisclosed” disclosures in this set?
8 of 18 rows are marked “Series Unknown” (for example, F4 Uranium on 2026-06-16 and Minga on 2024-02-13). Separately, 2 of 18 rows show “undisclosed” amounts (CRWN.ai on 2026-04-16 and Red Leaf Pulp on 2023-09-19), which limits comparisons for those entries.
Who sits at the extreme ends of the disclosed amounts?
The smallest disclosed amount in the rows shown is F4 Uranium’s $710K on 2026-06-16. The high end is Fission Uranium at $56M on 2024-02-05; no other disclosed entry approaches that level, with several others well below $10M (such as Vejii Holdings $140K on 2024-11-15 and Metalex Ventures $740K on 2024-12-16).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.